James Mechie

James Mechie

Product Design Engineering BSc

Exprimito

Chronic Venous Insufficiency (CVI) is a condition which affects approximately 580,000 people in the UK at any one time, at a cost of around £1.5bn annually. It reduces mobility, causing swelling and ulceration in the lower extremities. Exprimito is a medical device which aims to reduce the effects of CVI, thus providing an increased quality of life for the user, whilst also reducing the resources and high costs associated with treatment. The self-applicable design cuts out the need for costly professional treatment, whilst the peristaltic pneumatic compression gently promotes return blood flow back towards the heart. The inclusion of real-time blood-oxygen saturation level monitoring makes Exprimito applicable to a wider range of patients, preventing over-compression and possibility of arterial damage.